SCHEMBL28079180

SCHEMBL28079180

O=C(O)c1cc2cc(NC3CCNC3)ccc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMAD3 P84022 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ F7 P08709 1/20 0.46
▸ F3 P13726 1/20 0.46
▸ PIN1 Q13526 1/20 0.46
▸ PDPK1 O15530 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ APEX1 P27695 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ HRH3 Q9Y5N1 1/20 0.44
▸ MAPT P10636 1/20 0.42
▸ DAO P14920 1/20 0.42
▸ SRD5A2 P31213 1/20 0.42
▸ ITK Q08881 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2951373 0.83 MMP13 (0.60) KDM4EHPGDHSD17B10ALDH1A1LMNA
SCHEMBL2950369 0.78 HRH3 (0.53) SMAD3KDM4EHPGDHSD17B10F7
SCHEMBL2949966 0.76 HRH3 (0.51) SMAD3KDM4EHPGDHSD17B10F7
SCHEMBL2952598 0.76 HRH3 (0.53) SMAD3KDM4EHPGDHSD17B10F7
SCHEMBL2950114 0.76 HRH3 (0.73) SMAD3PIN1ALDH1A1HRH3KMT2A
SCHEMBL2943625 0.76 HRH3 (0.53) SMAD3KDM4EPIN1HRH3KMT2A
SCHEMBL2949495 0.75 HRH3 (0.50) SMAD3KDM4EHPGDHSD17B10F7
SCHEMBL15642795 0.75 SMAD3 (0.50) SMAD3KDM4EHPGDHSD17B10F7
SCHEMBL2951314 0.75 HRH3 (0.64) SMAD3KDM4EHPGDHSD17B10F7
SCHEMBL8197851 0.72 SMAD3 (0.60) SMAD3KDM4EHPGDHSD17B10F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105658625-A Indole amide compound as inhibitor of necrosis 株式会社LG生命科学 2016-06-08 — — CN disclosed
Send feedback